OCD clinical trials

Explore recruiting ocd clinical trials.

Recruiting ocd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

OCD trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Ramdomized non-inferiority clinical trial to evaluate the safety and efficacy of short duration therapy for non complicated enterococcal bacteremia.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Trial

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2a trial to evaluate the efficacy and safety of BP1.4979 in adult participants with obsessive compulsive disorder

Portugal, Spain, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blinded, placebo-controlled study of Rituximab in patients with Psychosis and/or Obsessive Compulsive Disorder, with an indication of immune system involvement.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

OCD trials by city

OCD in Toronto OCD in Vancouver OCD in Montreal OCD in Calgary OCD in Edmonton OCD in Ottawa OCD in Winnipeg OCD in Quebec City OCD in Hamilton OCD in Kitchener OCD in London OCD in Halifax OCD in New York OCD in Los Angeles OCD in Chicago OCD in Houston

Other conditions

Epilepsy ALS Huntington's disease Peripheral neuropathy Restless legs syndrome Essential tremor Dementia Depression Anxiety Bipolar disorder Schizophrenia PTSD ADHD Insomnia Postpartum depression Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough